Brief: Aeterna Zentaris Announces Continued Expansion Of Intellectual Property Portfolio For Macimorelin

COSCIENS Biopharma

31/07/2020 12:49

July 31 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS ANNOUNCES CONTINUED EXPANSION OF
INTELLECTUAL
PROPERTY PORTFOLIO FOR MACIMORELIN WITH ADDITIONAL PATENT
APPLICATIONS
    * AETERNA ZENTARIS - BASED ON POSITIVE RESULTS FROM
AEZS-130-P01,
CO FILED U.S. PROVISIONAL APPLICATION, PATENT APPLICATION UNDER
PERCENT
    * AETERNA ZENTARIS - BOTH PATENT APPLICATIONS RELATE TO
INVENTION
OF MACIMORELIN AS A METHOD TO DIAGNOSE GROWTH HORMONE DEFICIENCY
IN PEDIATRIC PATIENTS

Source text for Eikon:  ID:nGNX3SnvHP 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))